Healthcare101

  The global gene therapy market is undergoing a transformative evolution as healthcare systems increasingly shift toward precision medicine and curative therapies. According to recent industry analysis, the gene therapy market is projected to grow from USD 8.85 billion in 2024 to USD 36.55 billion by 2032, registering a robust CAGR of 19.4% during the forecast period. The rising burden of genetic disorders, rare diseases, and cancer, coupled with major advancements in genetic engineering technologies, is accelerating the adoption of gene therapy worldwide. Gene therapy represents one of the most innovative areas in modern medicine. Unlike traditional treatments that primarily manage symptoms, gene therapy focuses on correcting defective genes or modifying cellular functions to address the root cause of diseases. This revolutionary therapeutic approach is gaining strong momentum across neurology, oncology, hematology, and several rare genetic disorders. Download PDF Brochure Risi...

  The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2032, culminating in a forecasted valuation of US$717.3 million by the end of the period. The wireless digital stethoscopes segment accounted for the largest share of the global digital stethoscopes market in 2024. The digital stethoscopes market is divided into two segments based on connectivity: wireless digital stethoscopes and wired digital stethoscopes. Wireless digital stethoscopes dominate the market due to their superior mobility, user-friendly design, and seamless integration with telemedicine platforms. These devices enable real-time data transmission and remote auscultation, which are essential for modern healthcare delivery, especially in virtual consultations and remote patient monitoring. Their ability to streamline clinical workflows and enhance patient convenience has led to widespread ...

 The global healthcare industry is witnessing rapid transformation driven by the rise of biologics, vaccines, cell and gene therapies, and personalized medicines. At the center of this pharmaceutical evolution lies fill finish manufacturing — a critical stage in drug production responsible for ensuring sterile pharmaceutical products are accurately filled, sealed, packaged, and prepared for patient use. As pharmaceutical companies continue to expand biologic pipelines and increase vaccine production capacities, the demand for advanced fill finish technologies is growing substantially worldwide. The Fill Finish Manufacturing Market is valued at approximately USD 16.86 billion in 2025 and is projected to reach USD 28.14 billion by 2030, growing at a CAGR of 8.9% during the forecast period. This strong growth reflects increasing investments in sterile manufacturing technologies, automation systems, ready-to-use consumables, and high-capacity production facilities. Download PDF Br...

  Heart disease remains one of the leading causes of death worldwide, making early diagnosis and continuous monitoring more important than ever. Modern   cardiac monitoring devices   are helping healthcare professionals detect irregular heart activity, monitor chronic cardiovascular conditions, and improve patient outcomes through real-time data collection and advanced digital technologies. From wearable ECG monitors to implantable loop recorders, the cardiac monitoring industry is rapidly evolving with innovations in artificial intelligence, wireless connectivity, and remote patient monitoring. These technologies are reshaping how hospitals, clinics, and patients manage cardiovascular health. The global cardiac monitoring and cardiac rhythm management devices market, valued at USD 26.33 billion in 2025, stood at USD 27.90 billion in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 37.88 billion b...